Skip to content
The San Antonio

A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning

A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returning
Photo: KSAT 12 (ABC affiliate) · view original

A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. The vaccine was custom-brewed for each patient to match their tumor. Adding it to a standard...

Sources and story details